HQIP / Resources / National Diabetes Insulin Pump Audit Data Quality Statement, 2013-15
National Diabetes Insulin Pump Audit Data Quality Statement, 2013-15
Published: 01 Apr 2016
The Insulin Pump Audit is part of the National Diabetes Audit programme (NDA), and is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit programme (NCA). The NDA is managed by the Health and Social Care Information Centre (HSCIC) in partnership with Diabetes UK and is supported by Public Health England (PHE).
The Insulin Pump audit collects information on the number and characteristics of people with diabetes using an insulin pump, the reason for going on an insulin pump and the outcomes achieved since starting the pump. This is the first time that the NDA has included the opportunity to submit pump data. This first report provides preliminary national and local feedback about pump use and also assesses the ways in which changes to the data submission process could improve the analysis, feedback and information for the future. Accordingly, there are a number of data quality issues to be aware of when looking at this report regarding coverage and so appropriate caution should be exercised when interpreting the analyses.
National standards for the use of insulin pumps were set out in National Institute for Health and Clinical Excellence (NICE) guidance – Continuous Subcutaneous Insulin Infusion (CSII) for the treatment of diabetes mellitus (NICE technology appraisal guidance [TA151] Published date: July 2008).
The guidance states that Continuous subcutaneous insulin infusion (CSII) or ‘insulin pump’ therapy is recommended as a possible treatment for adults and children 12 years and over with Type 1 diabetes mellitus if:
attempts to reach target haemoglobin A1c (HbA1c) levels with multiple daily injections result in the person having ‘disabling hypoglycaemia’, or
HbA1c levels have remained high (70mmol (8.5%) or above) with multiple daily injections (including using long-acting insulin analogues if appropriate) despite the person and/or their carer carefully trying to manage their diabetes
The full data quality statement is available to download from this page.